RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study
dc.conference.date | SEP 19-OCT 18, 2020 | |
dc.conference.title | ESMO Virtual Congress | |
dc.contributor.author | Grande, E. | |
dc.contributor.author | Espinosa-Olarte, P. | |
dc.contributor.author | Serrano, R. | |
dc.contributor.author | Jimenez, P. | |
dc.contributor.author | Alonso, T. | |
dc.contributor.author | Benavent, M. | |
dc.contributor.author | Capdevila Castillon, J. | |
dc.contributor.author | Lacasta, A. | |
dc.contributor.author | Yaya Tur, R. | |
dc.contributor.author | Carmona, A. | |
dc.contributor.author | Gallegos, I. | |
dc.contributor.author | Rodriguez, R. M. | |
dc.contributor.author | Castillo Trujillo, A. O. | |
dc.contributor.author | Molina Cerrillo, J. | |
dc.contributor.author | Hernando, J. | |
dc.contributor.author | Bujedo Martinez, A. | |
dc.contributor.author | Garcia-Carbonero, R. | |
dc.contributor.authoraffiliation | [Grande, E.] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gallegos, I.] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Espinosa-Olarte, P.] Univ Hosp 12 Octubre, Dept Oncol, Pinto, Spain | |
dc.contributor.authoraffiliation | [Serrano, R.] Hosp Reina Sofia, IMIBIC CIBERONC, Med Oncol, Cordoba, Spain | |
dc.contributor.authoraffiliation | [Jimenez, P.] Hosp Univ Cent Asturias, Med Oncol, Oviedo, Spain | |
dc.contributor.authoraffiliation | [Alonso, T.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Molina Cerrillo, J.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Benavent, M.] Hosp Virgen del Rocio, Med Oncol, Seville, Spain | |
dc.contributor.authoraffiliation | [Capdevila Castillon, J.] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Hernando, J.] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Lacasta, A.] Hosp Donostia, Med Oncol, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Bujedo Martinez, A.] Hosp Donostia, Med Oncol, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Yaya Tur, R.] IVO Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Carmona, A.] Hosp Univ Morales Meseguer, Med Oncol, Murcia, Spain | |
dc.contributor.authoraffiliation | [Rodriguez, R. M.] Univ Hosp Reina Sofia, Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Castillo Trujillo, A. O.] Hosp Univ Cent Asturias HUCA, Dept Med Oncol, Oviedo, Spain | |
dc.contributor.authoraffiliation | [Garcia-Carbonero, R.] Univ Hosp 12 Octubre, 3Med Oncol Dept, Madrid, Spain | |
dc.contributor.funder | Pfizer | |
dc.date.accessioned | 2025-01-07T13:37:54Z | |
dc.date.available | 2025-01-07T13:37:54Z | |
dc.date.issued | 2020-09-01 | |
dc.identifier.doi | 10.1016/j.annonc.2020.08.1387 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753420413833/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/25711 | |
dc.identifier.wosID | 573469101461 | |
dc.issue.number | 4 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Reina Sofía | |
dc.organization | Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S777-S778 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 31 | |
dc.wostype | Meeting Abstract |